377 related articles for article (PubMed ID: 16399088)
21. Implications of heart failure drug trials: COMET, CHARM, EPHESUS.
Hiestand B; Abraham WT
Rev Cardiovasc Med; 2005; 6 Suppl 2():S4-11. PubMed ID: 15891699
[TBL] [Abstract][Full Text] [Related]
22. Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarction.
Weir R; McMurray JJ
Heart; 2005 May; 91 Suppl 2(Suppl 2):ii17-20; discussion ii31, ii43-8. PubMed ID: 15831602
[TBL] [Abstract][Full Text] [Related]
23. Advances in the treatment of heart failure with a preserved ejection fraction.
Das A; Abraham S; Deswal A
Curr Opin Cardiol; 2008 May; 23(3):233-40. PubMed ID: 18382212
[TBL] [Abstract][Full Text] [Related]
24. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
[TBL] [Abstract][Full Text] [Related]
25. [Effects of aldosterone receptor blocker therapy on cardiac remodeling].
Boccanelli A; Battagliese A
G Ital Nefrol; 2006; 23 Suppl 34():S57-63. PubMed ID: 16633997
[TBL] [Abstract][Full Text] [Related]
26. Therapy with cardiac contractility modulation electrical signals improves left ventricular function and remodeling in dogs with chronic heart failure.
Imai M; Rastogi S; Gupta RC; Mishra S; Sharov VG; Stanley WC; Mika Y; Rousso B; Burkhoff D; Ben-Haim S; Sabbah HN
J Am Coll Cardiol; 2007 May; 49(21):2120-8. PubMed ID: 17531662
[TBL] [Abstract][Full Text] [Related]
27. The HF epidemic: the need for new treatment strategies.
Carson PE
J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2 Suppl):S32-4. PubMed ID: 17199218
[TBL] [Abstract][Full Text] [Related]
28. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
van Veldhuisen DJ; Cohen-Solal A; Böhm M; Anker SD; Babalis D; Roughton M; Coats AJ; Poole-Wilson PA; Flather MD;
J Am Coll Cardiol; 2009 Jun; 53(23):2150-8. PubMed ID: 19497441
[TBL] [Abstract][Full Text] [Related]
29. Inotropic drugs and neurohormonal antagonists in the treatment of HF in the elderly.
O'Connor CM; Arumugham P
Clin Geriatr Med; 2007 Feb; 23(1):141-53. PubMed ID: 17126759
[TBL] [Abstract][Full Text] [Related]
30. Heart failure: recent advances in prevention and treatment.
Fonarow GC
Rev Cardiovasc Med; 2000; 1(1):25-33, 54. PubMed ID: 12457149
[TBL] [Abstract][Full Text] [Related]
31. Multicenter, randomized, double-blind, placebo-controlled study on the effect of oral tolvaptan on left ventricular dilation and function in patients with heart failure and systolic dysfunction.
Udelson JE; McGrew FA; Flores E; Ibrahim H; Katz S; Koshkarian G; O'Brien T; Kronenberg MW; Zimmer C; Orlandi C; Konstam MA
J Am Coll Cardiol; 2007 Jun; 49(22):2151-9. PubMed ID: 17543634
[TBL] [Abstract][Full Text] [Related]
32. Acute decompensated heart failure: best evidence and current practice.
Mehta R; Feldman D
Minerva Cardioangiol; 2005 Dec; 53(6):537-47. PubMed ID: 16333237
[TBL] [Abstract][Full Text] [Related]
33. Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure.
Lobmeyer MT; Gong Y; Terra SG; Beitelshees AL; Langaee TY; Pauly DF; Schofield RS; Hamilton KK; Herbert Patterson J; Adams KF; Hill JA; Aranda JM; Johnson JA
Pharmacogenet Genomics; 2007 Apr; 17(4):277-82. PubMed ID: 17496726
[TBL] [Abstract][Full Text] [Related]
34. [New therapeutic prospects in heart failure. ACE inhibitors and beta blockers].
Capone A; Carfagna P; Paravati V; Bianco G; Battista M; Brandimarte C
Recenti Prog Med; 1999 Mar; 90(3):136-42. PubMed ID: 10228352
[TBL] [Abstract][Full Text] [Related]
35. Heart failure update: treatment of heart failure with a normal left ventricular ejection fraction in the elderly.
Aronow WS
Geriatrics; 2006 Aug; 61(8):16-20. PubMed ID: 16901193
[TBL] [Abstract][Full Text] [Related]
36. Pharmacotherapy for heart failure with left ventricular dysfunction: beyond angiotensin-converting enzyme inhibitors and beta-blockers.
Norgard NB; Stark JE
Pharmacotherapy; 2008 Jul; 28(7):920-31. PubMed ID: 18576907
[TBL] [Abstract][Full Text] [Related]
37. Autoantibody against beta1-adrenergic receptor and left ventricular remodeling changes in response to metoprolol treatment.
Miao GB; Liu JC; Liu MB; Wu JL; Zhang G; Chang J; Zhang L
Eur J Clin Invest; 2006 Sep; 36(9):614-20. PubMed ID: 16919043
[TBL] [Abstract][Full Text] [Related]
38. [Prevention of heart failure].
Logeart D; Guiti C; Ennezat PV; Cohen-Solal A
Arch Mal Coeur Vaiss; 1998 Nov; 91(11):1333-41. PubMed ID: 9864601
[TBL] [Abstract][Full Text] [Related]
39. Managing the patient with diabetes mellitus and heart failure: issues and considerations.
Fonarow GC
Am J Med; 2004 Mar; 116 Suppl 5A():76S-88S. PubMed ID: 15019865
[TBL] [Abstract][Full Text] [Related]
40. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
Dulin BR; Krum H
Curr Opin Cardiol; 2006 Jul; 21(4):393-9. PubMed ID: 16755210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
